The Importance of Blood Inflammatory Parameters in the Assessment of Hemodynamically Significant Coronary Artery

Farhad Arefinia1, Ali Ghaemian2, Maysam Rezapour1

  • 1Department of Paramedical Sciences, Amol School of Paramedicine Sciences, Mazandaran University of Medical Sciences, Sari, Iran.

Insights

Inflammation markers like neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are linked to coronary artery disease (CAD) severity. Higher NLR and PLR correlate with reduced fractional flow reserve (FFR) in patients with moderate coronary lesions.

Area of Science:

  • Cardiology
  • Immunology
  • Medical Diagnostics

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Inflammation is a key factor in the development and progression of CAD.
  • Blood-based inflammatory markers may offer insights into CAD severity.

Purpose of the Study:

  • To evaluate the association between inflammatory ratios from blood counts and coronary lesion severity in CAD patients.
  • To assess the relationship between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) with fractional flow reserve (FFR) measurements.

Main Methods:

  • Retrospective analysis of 97 CAD patients with moderate coronary lesions.
  • Inclusion criteria based on fractional flow reserve (FFR) measurements.
  • Assessment of demographic data, laboratory results, NLR, PLR, and SII stratified by FFR categories.

Main Results:

  • Lower FFR (≤0.80) was associated with significantly higher NLR (P=0.009).
  • Increased NLR and SII correlated with a reduction in FFR (P=0.003).
  • Increased PLR also correlated with a reduction in FFR (P=0.011), though its association with FFR ≤0.80 was not statistically significant (P=0.0948).

Conclusions:

  • Blood inflammatory ratios, particularly NLR, show a significant association with FFR in CAD patients with moderate coronary lesions.
  • These findings suggest a potential role for inflammatory markers in assessing the hemodynamic significance of intermediate coronary stenosis.
  • Further research is warranted to confirm the prognostic value of these markers in guiding clinical decisions for CAD management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
217
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
341
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
1.5K
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
916
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40